The present study demonstrated that formosanin C may be an effective ferroptosis inducer in CRC cells with p53 or oncogenic KRAS, and our novel gene-expression screening platform via the integrated analysis of differentially expressed genes and pathways may allow for the precise identification of potential naturally occurring compounds capable of targeting specific diseases. The gene discussed is KRAS; the disease is colorectal carcinoma.